These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 3471304)

  • 1. Dexamethasone suppression test and the response to antidepressant depending on their central monoaminergic action in major depression.
    Benkelfat C; Poirier MF; Léouffre P; Gay C; Löo H
    Can J Psychiatry; 1987 Apr; 32(3):175-8. PubMed ID: 3471304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A double-blind comparative clinical trial of citalopram vs maprotiline in hospitalized depressed patients.
    Timmerman L; de Beurs P; Tan BK; Leijnse-Ybema H; Sanchez C; Høpfner Petersen HE; Cohen Stuart MH
    Int Clin Psychopharmacol; 1987 Jul; 2(3):239-53. PubMed ID: 2447151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The dexamethasone suppression test and antidepressant response in major depression.
    Simon JS; Evans DL; Nemeroff CB
    J Psychiatr Res; 1987; 21(3):313-7. PubMed ID: 3681765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dexamethasone suppression test as an aid for selection of specific antidepressant drugs in patients with endogenous depression.
    Rihmer Z; Arató M; György S; Révai K; Demeter E
    Pharmacopsychiatry; 1985 Sep; 18(5):306-8. PubMed ID: 4048265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma tryptophan and tyrosine ratios to competing amino acids in relation to antidepressant response to citalopram and maprotiline. A preliminary study.
    Møller SE; de Beurs P; Timmerman L; Tan BK; Leijnse-Ybema HJ; Stuart MH; Petersen HE
    Psychopharmacology (Berl); 1986; 88(1):96-100. PubMed ID: 3080781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urinary 3-methoxy, 4-hydroxyphenylethylene glycol and therapeutic response to maprotiline and indalpine in major depression.
    Loo H; Benkelfat C; Vanelle JM; Dennis T; Poirier MF; Olie JP; Scatton B
    J Neural Transm; 1986; 66(1):47-58. PubMed ID: 3734775
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Citalopram versus maprotiline: a controlled, clinical multicentre trial in depressed patients.
    Bouchard JM; Delaunay J; Delisle JP; Grasset N; Mermberg PF; Molczadzki M; Pagot R; Richou H; Robert G; Ropert R
    Acta Psychiatr Scand; 1987 Nov; 76(5):583-92. PubMed ID: 3324648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma 3,4-dihydroxyphenylethyleneglycol and therapeutic response to maprotiline and indalpine in major depression.
    Lôo H; Benkelfat C; Poirier MF; Vanelle JM; Olié JP; Dennis T; Scatton B
    Neuropsychobiology; 1986; 15(2):62-7. PubMed ID: 3762900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic and therapeutic value of testing stimulation of thyroid-stimulating hormone by thyrotropin-releasing hormone in 100 depressed patients.
    Vanelle JM; Poirier MF; Benkelfat C; Galinowski A; Sechter D; Suzini de Luca H; Lôo H
    Acta Psychiatr Scand; 1990 Feb; 81(2):156-61. PubMed ID: 2109497
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Maprotiline in pain-depression.
    Lindsay PG; Olsen RB
    J Clin Psychiatry; 1985 Jun; 46(6):226-8. PubMed ID: 3888970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serotonin reuptake inhibition vs. norepinephrine reuptake inhibition: a double-blind differential-therapeutic study with fluvoxamine and oxaprotiline in endogenous and neurotic depressives.
    Emrich HM; Berger M; Riemann D; von Zerssen D
    Pharmacopsychiatry; 1987 Mar; 20(2):60-3. PubMed ID: 3108909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is the dexamethasone suppression test predictive of response to specific antidepressant treatment in major depression?
    Steardo L; Barone P; Monteleone P; Iovino M; Cardone G
    Acta Psychiatr Scand; 1987 Aug; 76(2):129-33. PubMed ID: 2890265
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison between a serotonin and a noradrenaline reuptake blocker in the treatment of depressed outpatients. A cross-over study.
    Nyström C; Hällström T
    Acta Psychiatr Scand; 1987 Apr; 75(4):377-82. PubMed ID: 3035878
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Maprotiline in affective illness. Plasma concentration and clinical response.
    Norman TR; Burrows GD; Maguire KP; McIntyre IM; Scoggins BA
    J Affect Disord; 1983 May; 5(2):147-54. PubMed ID: 6222094
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison between a serotonin and a noradrenaline reuptake blocker in the treatment of depressed outpatients. Biochemical aspects.
    Nyström C; Ross SB; Hällström T; Kelder D
    Acta Psychiatr Scand; 1986 Feb; 73(2):133-8. PubMed ID: 2939691
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of depression with maprotiline hydrochloride: multicenter evaluation of efficacy and tolerability.
    Clin Ther; 1983; 5(4):377-84. PubMed ID: 6347381
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Ambulatory treatment of larvate depressions with maprotiline ].
    Vencovský E
    Cesk Psychiatr; 1982 Jun; 78(3):185-9. PubMed ID: 7116496
    [No Abstract]   [Full Text] [Related]  

  • 18. [Study of the metabolism of cerebral noradrenaline in depressed patients by the assay of plasma dihydroxyphenylethylene glycol].
    Loo H; Scatton B; Poirier MF; Benkelfat C; Dennis T; Vanelle JM; Garreau M; Sechter D
    Presse Med; 1985 Jun; 14(25):1363-6. PubMed ID: 3161030
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Double-blind comparison between a serotonin and a noradrenaline reuptake blocker in the treatment of depressed outpatients. Clinical aspects.
    Nyström C; Hällström T
    Acta Psychiatr Scand; 1985 Jul; 72(1):6-15. PubMed ID: 2930998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recognizing and treating depressed patients with maprotiline.
    Lerfald SC
    Md State Med J; 1982 Nov; 31(11):44-7. PubMed ID: 7176695
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.